Accolade Stock

Accolade Gross Margin

Delisted·Apr 7, 2025

The Gross Margin of Accolade (ACCD) as of Aug 8, 2026 is 46.36 %. In the previous year, Gross Margin was 45.23 % — a change of 2.50% (higher).

Gross Margin

46.36 %

YoY

2.50%

Last updated:

Gross Margin of Accolade is 2026 46.36 % . Gross Margin of Accolade was 2025 45.23 % . It decreases by 2.50% higher compared to the previous year.

For Accolade, the gross margin of 47.0% is up versus 45.4% a few years ago.

Access this data via the Eulerpool API

Accolade Stock analysis

What does Accolade do? Accolade Inc is a US-American company based in Seattle. The company was founded in 2007 by Rajeev Singh and Mike Hilton and has since developed into a leading healthcare consulting firm. Accolade aims to make healthcare simple and affordable for everyone. The company offers a wide range of solutions to its customers. It provides services to employers, insurance companies, and health authorities. Their main focus is on supporting patients and employees in their healthcare. They also offer services to health insurance companies and health authorities. The business model of Accolade involves close collaboration between the customers and the company. Patients are supported by a "Health Assistant," who are trained professionals that help patients make the best decisions regarding their health. Factors such as finding the best providers, medication delivery, clinical tests, and alternative options are considered. Accolade's mission is to improve healthcare for everyone by providing the best solutions. The company has divided itself into several different divisions to offer its services more effectively. The various divisions of Accolade include healthcare consulting, medication management, patient access and health navigation, client support, and health optimization. Accolade has become an important healthcare service provider and has earned a good reputation in the industry. The company is known for providing comprehensive and high-quality services that focus on individual patient care. When it comes to achieving improvements in care and the entire healthcare system, Accolade is an important partner that helps companies and individuals achieve their goals and lead healthier lives. Accolade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accolade stock

Gross Margin of Accolade is 46.36 % in 2026.

Gross Margin of Accolade changed from 45.23 % to 46.36 %, representing a 2.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Accolade since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Accolade with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Accolade

All Key Metrics — Accolade